North America Avidin Market Size & Outlook, 2026-2034


North America Avidin Market Insights

  • According to Reed Intelligence analysis, the North America Avidin Market size stood at USD 77.42 Million in 2025 and is forecasted to reach USD 147.81 Million by 2034.
  • The market is projected to grow at a CAGR of 7.46% between 2026 and 2034.
  • By segment, Avidin was the leading Type in terms of market size in 2025.
  • Streptavidin is expected to be the most lucrative Type segment, exhibiting the fastest growth throughout the forecast period.

Other Key Findings


  • The global Avidin Market size saw North America holding a share of 36.01% in 2025.
  • United States is forecasted to account for the leading share of the global market by 2034.
  • In North America, United States is forecasted to be the fastest-expanding market, projected to reach USD 115.03 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 77.42 Million
Market Size In 2034 USD 147.81 Million
Largest segment Avidin
Units Revenue in USD Million
CAGR 7.46% (2026-2034)
Segmnetation Covered
North America
  1. United States
  2. Canada
Type
  1. Avidin
  2. Streptavidin
  3. Neutravidin
Application
  1. Immunoassays
  2. Molecular Diagnostics
  3. Protein Purification
  4. Research and Development
End-Use
  1. Biotechnology and Pharmaceutical Companies
  2. Academic and Research Institutes
  3. Diagnostic Laboratories
Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Middle East Africa
  5. Latin America
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends